Sagility buys US healthcare firm Chirok Health for up to US$32 million
- Mergers & acquisitions
- Business Services
Sagility (NSE: SAGILITY) agreed to buy 100% of Chirok Health LLC, a US healthcare services company, through a wholly owned subsidiary, for an upfront US$20 million in cash plus up to US$12.35 million tied to performance milestones, it said in a filing on 21 Oct 2026. The company’s market value is ₹20,781 crore, and its consolidated revenue for the quarter ended 30 Jun 2026 was ₹1,977.81 crore.
Key highlights
- Upfront payment: US$20.0 million at closing, subject to customary adjustments
- Contingent consideration: up to US$12.35 million on performance milestones
- Aggregate price: up to US$32.35 million, all in cash
- Chirok turnover: US$9.0 million in CY2025, US$8.2 million in CY2024 and US$12.7 million in CY2023
- Stake acquired: 100%, with no promoter or group interest
Sign up to continue reading
Create a free account to read the rest of this article and the analysis that follows.
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.
